Literature DB >> 28441240

Emergency Department Management of Bronchiolitis in the United States.

Constance Gong, Terri Byczkowski1, Constance McAneney1, Monika K Goyal2, Todd A Florin1.   

Abstract

OBJECTIVE: The aim of this study was to examine differences between general and pediatric emergency departments (PEDs) in adherence to the American Academy of Pediatrics bronchiolitis management guidelines.
METHODS: We conducted a nationally representative study of ED visits by infants younger than 24 months with bronchiolitis from 2002 to 2011 using the National Hospital Ambulatory Medical Care Survey. Diagnostic testing (complete blood counts, radiographs) and medication use (albuterol, corticosteroids, antibiotics and intravenous fluids) in general emergency departments (GEDs) were compared with those in PEDs before and after 2006 American Academy of Pediatrics guideline publication. Weighted percentages were compared, and logistic regression evaluated the association between ED type and resource use.
RESULTS: Of more than 2.5 million ED visits for bronchiolitis from 2002 to 2011, 77.3% occurred in GEDs. General emergency departments were more likely to use radiography (62.7% vs 42.1%; adjusted odds ratio [aOR], 2.4; 95% confidence interval [CI], 1.4-4.1), antibiotics (41.3% vs 18.8%; aOR, 2.8; 95% CI, 1.5-5.2), and corticosteroids (24.3% vs 12.5%; aOR, 2.1; 95% CI, 1.0-4.5) compared with PEDs. Compared with preguideline, after guideline publication PEDs had a greater decrease in radiography use (-19.7%; 95% CI, -39.3% to -0.03%) compared with GEDs (-12.2%; 95% CI, -22.3% to -2.1%), and PEDs showed a significant decline in corticosteroid use (-12.4%; 95% CI, -22.1% to -2.8%), whereas GEDs showed no significant decline (-4.6%; 95% CI, -13.5% to 4.3%).
CONCLUSIONS: The majority of ED visits for bronchiolitis in the United States occurred in GEDs, yet GEDs had increased use of radiography, corticosteroids, and antibiotics and did not show substantial declines with national guideline publication. Given that national guidelines discourage the use of such tests and treatments in the management of bronchiolitis, efforts are required to decrease ED use of these resources in infants with bronchiolitis, particularly in GEDs.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 28441240      PMCID: PMC5654708          DOI: 10.1097/PEC.0000000000001145

Source DB:  PubMed          Journal:  Pediatr Emerg Care        ISSN: 0749-5161            Impact factor:   1.454


  39 in total

Review 1.  Words without action? The production, dissemination, and impact of consensus recommendations.

Authors:  J Lomas
Journal:  Annu Rev Public Health       Date:  1991       Impact factor: 21.981

2.  Understanding and interpreting the National Hospital Ambulatory Medical Care Survey: key questions and answers.

Authors:  Linda F McCaig; Catharine W Burt
Journal:  Ann Emerg Med       Date:  2012-10-18       Impact factor: 5.721

3.  Clinical practice guideline: the diagnosis, management, and prevention of bronchiolitis.

Authors:  Shawn L Ralston; Allan S Lieberthal; H Cody Meissner; Brian K Alverson; Jill E Baley; Anne M Gadomski; David W Johnson; Michael J Light; Nizar F Maraqa; Eneida A Mendonca; Kieran J Phelan; Joseph J Zorc; Danette Stanko-Lopp; Mark A Brown; Ian Nathanson; Elizabeth Rosenblum; Stephen Sayles; Sinsi Hernandez-Cancio
Journal:  Pediatrics       Date:  2014-11       Impact factor: 7.124

4.  Pediatric emergency departments are more likely than general emergency departments to treat asthma exacerbation with systemic corticosteroids.

Authors:  Arpi Bekmezian; Adam L Hersh; Judith H Maselli; Michael D Cabana
Journal:  J Asthma       Date:  2010-11-30       Impact factor: 2.515

5.  No impact from active dissemination of the Ottawa Ankle Rules: further evidence of the need for local implementation of practice guidelines.

Authors:  C Cameron; C D Naylor
Journal:  CMAJ       Date:  1999-04-20       Impact factor: 8.262

6.  Bronchiolitis management before and after the AAP guidelines.

Authors:  Kavita Parikh; Matthew Hall; Stephen J Teach
Journal:  Pediatrics       Date:  2013-12-02       Impact factor: 7.124

7.  Effects of the National Institutes of Health Consensus Development Program on physician practice.

Authors:  J Kosecoff; D E Kanouse; W H Rogers; L McCloskey; C M Winslow; R H Brook
Journal:  JAMA       Date:  1987-11-20       Impact factor: 56.272

8.  Screening guidelines for Chlamydia trachomatis infection. Evaluating physician awareness, agreement, and use.

Authors:  K Weyman; A R Lanning
Journal:  Can Fam Physician       Date:  1995-02       Impact factor: 3.275

9.  The awareness-to-adherence model of the steps to clinical guideline compliance. The case of pediatric vaccine recommendations.

Authors:  D E Pathman; T R Konrad; G L Freed; V A Freeman; G G Koch
Journal:  Med Care       Date:  1996-09       Impact factor: 2.983

10.  Evaluation of the utility of radiography in acute bronchiolitis.

Authors:  Suzanne Schuh; Amina Lalani; Upton Allen; David Manson; Paul Babyn; Derek Stephens; Shannon MacPhee; Matthew Mokanski; Svetlana Khaikin; Paul Dick
Journal:  J Pediatr       Date:  2007-04       Impact factor: 4.406

View more
  5 in total

1.  Patient, Provider, and Health Care System Characteristics Associated With Overuse in Bronchiolitis.

Authors:  Elizabeth R Wolf; Alicia Richards; Martin Lavallee; Roy T Sabo; Alan R Schroeder; Matthew Schefft; Alex H Krist
Journal:  Pediatrics       Date:  2021-09-23       Impact factor: 9.703

2.  Low-Value Diagnostic Imaging Use in the Pediatric Emergency Department in the United States and Canada.

Authors:  Eyal Cohen; Jonathan Rodean; Christina Diong; Matt Hall; Stephen B Freedman; Paul L Aronson; Harold K Simon; Jennifer R Marin; Margaret Samuels-Kalow; Elizabeth R Alpern; Rustin B Morse; Samir S Shah; Alon Peltz; Mark I Neuman
Journal:  JAMA Pediatr       Date:  2019-08-05       Impact factor: 16.193

3.  Impact of bronchiolitis guidelines publication on primary care prescriptions in the Italian pediatric population.

Authors:  Elisa Barbieri; Anna Cantarutti; Sara Cavagnis; Luigi Cantarutti; Eugenio Baraldi; Carlo Giaquinto; Daniele Donà
Journal:  NPJ Prim Care Respir Med       Date:  2021-03-19       Impact factor: 2.871

4.  Healthcare cost attributable to bronchiolitis: A population-based cohort study.

Authors:  Beate Sander; Yaron Finkelstein; Hong Lu; Chenthila Nagamuthu; Erin Graves; Lauren C Ramsay; Jeffrey C Kwong; Suzanne Schuh
Journal:  PLoS One       Date:  2021-12-02       Impact factor: 3.240

5.  Impact of the updating of clinical guidelines for RSV bronchiolitis on the use of diagnostic testing and medications in tertiary hospitals in Colombia.

Authors:  Jefferson Antonio Buendía; Diana Guerrero Patiño
Journal:  Pan Afr Med J       Date:  2022-07-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.